The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Anhedonia predicts poor psychosocial functioning: Results from a large cohort of patients treated for major depressive disorder by general practitioners
Abstract
BACKGROUND: Anhedonia is a core symptom of major depression and a key prognostic factor that is often poorly explored in clinical trials of major depressive disorder (MDD). Beyond symptomatic remission, psychosocial functioning also reveals difficulty in achieving remission in patients with MDD. The main objective of this study was to explore the interrelationships between social functioning and anhedonia on a longitudinal basis. METHODS: In total, 1570 outpatients treated for MDD with agomelatine were included. Severity of depression and levels of anhedonia and of psychosocial functioning were assessed at inclusion and at 10-14 weeks, with specific standardized scales (MADRS, QFS, SHAPS, CGI). Multivariate regression and mediation analyses were performed. RESULTS: Using multivariate regression, we showed that improvement of anhedonia was the strongest predictor of improvement in psychosocial functioning (odds ratio=7.3 [4.3-12.1] P<0.0001). In addition, mediation tests confirmed that the association between improvement of depressive symptoms and improvement of social functioning was significantly underpinned by the improvement of anhedonia over time. Finally, we explored the determinants of the dissociation of the response, i.e., the persistence of psychosocial dysfunctioning despite a symptomatic response to antidepressant treatment, which remains a widespread situation in clinical practice. We showed that this dissociation was strongly predicted by persistence of anhedonia. CONCLUSION: Our results suggest that anhedonia is one of the strongest predictors of psychosocial functioning, along with symptomatic remission, and should be carefully assessed by health professionals, in order to optimize pharmacological as well as non-pharmacological management of depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and improvement of anhedonia is a strong predictor for improvement in psychosocial functioning (Vinckier et al., 2017).”
From Circuit Mechanisms of Reward, Anhedonia, and Depression (2019) · cites this paper as Vinckier et al., 2017
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The clinical global impressions scale: applying a research tool in clinical practice.
Busner, J., & Targum, S. D. (2007) · PubMed Central · Cited by 1,963
A scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale
Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.1.99 · Cited by 1,778
The neurobiology of anhedonia and other reward-related deficits
Der-Avakian, A., & Markou, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.005 · Cited by 1,130
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Psychosocial Disability During the Long-term Course of Unipolar Major Depressive Disorder
Judd, L. L., Akiskal, H. S., Zeller, P. J., Paulus, M., Leon, A. C., Maser, J. D., Endicott, J., Coryell, W., Kunovac, J. L., Mueller, T. I., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.375 · Cited by 593
Social Functioning in Depression: A Review
Hirschfeld, R. M. A., Montgomery, S. A., Keller, M. B., Kasper, S., Schatzberg, A. F., Moller, H.-J., Healy, D., Baldwin, D., Humble, M., Versiani, M., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0405 · Cited by 586
Assessing anhedonia in depression: potentials and pitfalls
Rizvi, S. J., Pizzagalli, D. A., Sproule, B. A., & Kennedy, S. H. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.004 · Cited by 571
Treatments of Depression and the Functional Capacity to Work
Mintz, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100005001 · Cited by 561
McMakin, D. L., Olino, T. M., Porta, G., Dietz, L. J., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Ryan, N. D., Birmaher, B., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.011 · Cited by 448
Research works printed but not linked: 1
- Loas, 1997, Étude de validation de la version française de l’échelle de plaisir de Snaith et Hamilton (Snaith-Hamilton Pleasure Scale, SHAPS, Snaith et al., 1995): détermination des paramètres métrologiques chez 208 sujets sains et chez 103 malades hospitalisés présentant une dépression ou une schizophrénie, Encephale, 23, 454
Cited by
Sorted by citations
Items 101–200 of 201
Kale, H. P., Cambron‐Mellott, M. J., Drissen, T., Perkowski, K., King-Concialdi, K., & Jha, M. K. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf048 · Cited by 6
“8,16 While some studies have assessed the association o f anhe-donia with HRQoL, 15,17 employment status , 18 social interactions , 19 and psychosocial functioning, 13 they were limited by small sample sizes and to non-US populations.”
Pugh, D., Saunders, R., Jones, A., Dunn, B. D., & Buckman, J. E. J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120165 · Cited by 7
Li, S., Zhang, J., Liu, C., Wang, L.-L., Hu, H., Chu, M., Wang, Y., Lv, Q., Lui, S. S. Y., Yi, Z., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01934-5 · Cited by 5
“Moreover, anhedonia is the hallmark symptom for diagnosing MDD [ 12] and also impedes recovery and psychosocial functioning in these patients [ 13–15].”
Boyle, C. C., Cole, S. W., Irwin, M. R., Eisenberger, N. I., & Bower, J. E. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100588 · Cited by 7
“, 2015), poorer psychosocial function (Vinckier et al., 2017), and elevated risk for disability, death (Davidson et al.”
BackgroundLin, S., Liu, R., Zhang, Z., Liu, F., Qin, S., Wei, Y., & Wang, F. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05378-4 · Cited by 6
“In a large sample (N = 1,570) of patients with major depression, Vinckier et al. showed that anhedonia was the strongest predictor of improvement in psychosocial functioning [12].”
BackgroundLiu, X., & Read, S. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1349576 · Cited by 6
Anhedonia in depressive disorders
Siwek, M. (2017) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2017.0026 · Cited by 5
Berg, H. E., Eun, Y.-J., Yu, X., McDermott, T. J., Akeman, E., Kuplicki, R., Yeh, H., Thompson, W. K., Martell, C. R., Wolitzky-Taylor, K. B., et al. (2025) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2025.100107 · Cited by 6
Heise, M., Ji, J. L., Werthmann, J., & Renner, F. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104707 · Cited by 4
“Higher levels of anhedonia have also been found to predict a worse clinical course of depression (Morris et al., 2009) and reduced psychosocial functioning following recovery (Vinckier et al., 2017).”
McAuley, S., & Kangas, M. (2025) · Clinical Psychologist · doi:10.1080/13284207.2025.2498394 · Cited by 4
How emotional expressions motivate actionPreprint
Mennella, R., & Grèzes, J. (2023) · doi:10.31234/osf.io/vfbcp · Cited by 4
Liang, S., Gao, Y., Palaniyappan, L. K., Song, X. M., Zhang, T., Han, J., Tan, Z., & Li, T. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.003 · Cited by 3
Fung, H., Potash, R. M., Krystal, A. D., Pizzagalli, D. A., & Sacchet, M. D. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02125-z · Cited by 3
“Conversely, the amelioration of anhedonia is correlated with better quality of life in individuals with mood disorders [5] and improved psychosocial functioning in MDD patients [6].”
Which aspects of anhedonia predict response to pharmacotherapy in major depressive disorder?
Uher, R., Rizvi, S. J., Quilty, L. C., Pavlová, B., Nunes, A., Foster, J. A., Lam, R. W. M., Milev, R. V., Müller, D. J., Taylor, V., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725102894 · Cited by 3
“…anhedonia predict the persistence of depression, lack of functional recovery, and suicide attempts among adolescents and adults with MDD (Fawcett et al., 1990; Gabbay et al., 2015; Luca et al., 2024; Sagud et al., 2021; Spijker, Bijl, de Graaf, & Nolen, 2001; Vinckier, Gourion, & Mouchabac, 2017).”
Sgherza, T. R., Becerra, R., Bylsma, L. M., Fresco, D. M., & Naragon‐Gainey, K. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121517 · Cited by 3
He, T., Zou, H., Hou, H., Yu, Y., Wang, F., Tian, C., Luo, D., Yang, Z., Zhao, J., & Yang, B. X. (2024) · International Journal of Social Psychiatry · doi:10.1177/00207640241291495 · Cited by 3
“…Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), anhedonia and sad mood are defined as core symptoms of depression, and the improvement of anhedonia is considered as a strong predictor for the restoration of psychosocial function (Vinckier et al., 2017).”
Prevalence of anhedonia in women with deep endometriosis
Mallorquí, A., Fortuna, A., Segura, E., Cardona, G. G., Espinosa, M., Quintas, L., Gràcia, M., Angulo-Antúnez, E., Carmona, F., & Martínez‐Zamora, M. Á. (2025) · Scientific Reports · doi:10.1038/s41598-024-84772-8 · Cited by 3
“Moreover, anhedonia has been linked to a higher incidence of life-time suicide attempts 47 , an increased risk of suicide 48 , and has been identified as a robust predictor of poor psychosocial functioning 49 .”
Santopetro, N. J., Luby, J. L., Barch, D. M., Luking, K. R., Hennefield, L., Gilbert, K., Whalen, D. J., & Hajcak, G. (2025) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-025-01293-2 · Cited by 3
“For example, P300 deficits in depression may be specific to symptoms of anhedonia (Urretavizcaya et al., 2003; Santopetro et al., 2021a, b, c, 2022), a particularly pernicious core symptom of depression linked to a more chronic and recurrent course and treatment resistance (Vinckier et al., 2017).”
Demetriou, K., Widnall, E., Warbrick, L. A., Reed, N., Marchant, K., Geschwind, N., Watson, R., Magner-Parsons, I., Barter, R., Wright, K. A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088726 · Cited by 3
Anhedonia as a Core Symptom of Depression and a Construct for Biological Research
Al‐Soleiti, M., Voort, J. L. V., & Singh, B. (2025) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20240050 · Cited by 4
Recovery-Oriented Psychopharmacological Interventions in Schizophrenia
Mallet, J., Strat, Y. L., Dubertret, C., & Gorwood, P. A. P. M. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_9 · Cited by 3
Herr, K. J., Berk, M., Huang, W., Kato, T., Lee, J. G., Ng, C. G., Wang, Z., Webb, T., Kasahara‐Kiritani, M., & Vandervoort, L. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70007 · Cited by 3
“A large prospective cohort study reported anhedonia as the strongest predictor of poor psychosocial functioning in MDD-ANH patients [9], leading to higher overall disease severity [12].”
Agomelatine – pharmacological properties and use in psychiatric practice
Siwek, M., Wasik, A., Krupa, A. J., & Oddział Kliniczny Psychiatrii Dorosłych, D. I. M. (2019) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2019.0019 · Cited by 2
The impact of rumination and anhedonia on daily social and occupational function
Gorrell, S., Divers, R. M., Boxley, L., & Fournier, J. C. J. (2025) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2025.2526650 · Cited by 2
“…has been identified to have different neuroa-natomical correlates than RNT, primarily in reward networks (Der-Avakian & Markou, 2012), higher anhe-donia has been correlated with the same cognitive inef-ficiencies and functional difficulties as RNT (McIntyre et al., 2016; Vinckier et al., 2017).”
Benedetto, S., Ionescu, A., Ge, T., Furey, M., Lin, S., Jha, M. K., Krystal, A. D., Shah, A. A., Walling, D. P., Shah, N., et al. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002046 · Cited by 2
A lasma rotein rofile of ntidepressant esponse to omega-3 atty cids
Lindahl, J., Stiernborg, M., Ventorp, F., Suneson, K., Veibäck, G. S., Tjernberg, J., Ståhl, D., Hjärn, M., Lavebratt, C., & Lindqvist, D. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111481 · Cited by 2
Beckett, C. W., & Lawson, R. P. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120731 · Cited by 2
Angedonia in the structure of affective disorders: therapeutic opportunities
Kasimova, L. N., & Svyatogor, M. V. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119111116 · Cited by 2
Durazzo, T. C., Humphreys, K. N., & LaRocca, M. A. (2023) · Military Medicine · doi:10.1093/milmed/usad405 · Cited by 2
Almeida, T. M., Generoso, I. P., Rosa, D. A. A., Pinheiro, T. B., Foletto, L. D., Jorge, G. M. T., Grilo, L. B., da Silva, U. R. L., Cordeiro, Q., & Uchida, R. R. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100829 · Cited by 2
Dolcetti, E., Annovazzi, P. O. L., Clerico, M., Cocco, E. E., Conte, A., Marfia, G. A., Salvetti, M., Tomassini, V., Clerici, V. T., Totaro, R., et al. (2024) · Current Neuropharmacology · doi:10.2174/011570159x326862240909105845 · Cited by 2
“…such as selective serotonin reuptake inhibitors and serotonin (SSRI) and noradrenaline reuptake inhibitors (SNRI), showed a limited benefit on anhedonia [22], with scattered evidence of efficacy in this direction for new anti-depressant drugs, such as agomelatine [23-27], and ketamine [28, 29].”
Learn to be happy—an experimental study in clinical context with depressive patients in Germany
Sequeira-Nazaré, E. R., & Schmitz, B. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1426597 · Cited by 2
Rosar, P. A., Traebert, J. L., Kaster, M. P., Bello, A. F., Haviaras, A. C., Gard, D. E., & Díaz, A. P. (2020) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2020-0131 · Cited by 1
Trajectories of anhedonia symptoms after traumatic injury
Piña, I., Timmer‐Murillo, S. C., Larson, C. L., deRoon‐Cassini, T. A., & Tomas, C. W. (2024) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2024.100408 · Cited by 1
Prizeman, K., & McCabe, C. (2025) · British Journal of Clinical Psychology · doi:10.1111/bjc.70008 · Cited by 2
“Our findings are consistent with previous longitudinal research on anhedonia predicting depression (Barkus & Badcock, 2019; Gabbay et al., 2015; Khazanov et al., 2020; Mathew et al., 2011; Serretti, 2023; Spijker et al., 2001; Tan et al., 2020; Vinckier et al., 2017; Winer et al., 2017).”
Kale, H. P., Ganz, M. L., Ghosh, R., Saiontz-Martinez, C., Drissen, T., & Cutler, A. J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120147 · Cited by 1
How Emotional Expressions Motivate Action
Mennella, R., & Grèzes, J. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009342919.026 · Cited by 4
Yue, Y., Zhang, J., Li, Y., Ma, X., Chen, G., Zhu, Z., Chen, S., Chen, Y., You, L., Tan, L., et al. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s549538 · Cited by 1
Lee, B., Kim, Y., Eum, H., Koo, J. S., Herr, K. J., Vandervoort, L., & Lee, J. G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334525 · Cited by 2
“Notably, anhedonia is reported in over 82% of patients with MDD [11,14] and is associated with severe cognitive and psychosocial impairment [15,16], greater depression severity [15,17], heightened suicidal ideation [18], reduced health-related quality of life (HRQoL) [19], and poor treatment…”
Pan, M., Zou, H., Luo, D., Wang, X. Q., Liu, Q., Shen, M., Li, X., Gong, X., & Yang, B. X. (2025) · Nursing Reports · doi:10.3390/nursrep15110384 · Cited by 1
“A large-scale cohort study had shown that the improvement of anhedonia was the strongest predictor of the improvement in the psychological and social functions of patients with MDD [16].”
Rajesh, S., Johnson, S. U., Hoffart, A., Leigh, E., & Ebrahimi, O. V. (2025) · Depression and Anxiety · doi:10.1155/da/5674096 · Cited by 1
“It is associated with outcomes such as poorer psychosocial functioning [14] and increased suicidal ideation [15], with these being prominent in university students [16].”
Bernier, V., Mungo, A., Point, C., Wacquier, B., Loas, G., & Hein, M. (2025) · Medicina · doi:10.3390/medicina61122125 · Cited by 1
“Furthermore, even if this symptomatic response to antidepressant treatment is present, the persistence of anhedonia complaints may favor the maintenance of alterations in psychosocial functioning in MDD subjects [6].”
Kachlik, Z., Cubała, W. J., Walaszek, M., Pastuszak, M., Pastuszak, K., & Kwaśny, A. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253251412629 · Cited by 1
Yang, J., Jia, Y., Chen, K., Liang, W., Long, J., Li, M., Wei, Q., Wang, J., Yan, B., Li, K., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1740789 · Cited by 1
Luo, X., Wu, Y., Yuan, L., Wang, Y., Li, J., Xu, P., Lian, J., Liu, X. Y., & Shen, Z. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s577735 · Cited by 1
Clinical correlates of anhedonia non-response to ketamine in treatment-resistant depression
Walaszek, M., Cubała, W. J., Kachlik, Z., Pastuszak, M., Pastuszak, K., & Kwaśny, A. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121762 · Cited by 1
Anhedonia in patients with major depressive disorder (MDD): State-of-the-art consensus review
Cutler, A. J., Clayton, A. H., Krystal, A. D., Maletic, V., McIntyre, R. S., & Nemeroff, C. B. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117225 · Cited by 3
Anhedonia as a transdiagnostic construct: implications for clinical practice and research
Matteo, I. D., Lavigne, K. M., & Raucher‐Chéné, D. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10793 · Cited by 1
Depression-specific P300 deficits compared to other forms of internalizing psychopathology
Thompson, B., Santopetro, N. J., Albanese, B. J., & Schmidt, N. B. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100865 · Cited by 1
Wang, Q., Wu, Y., Zhang, Y., Li, K., Su, Y., & Si, T. (2025) · BMC Psychology · doi:10.1186/s40359-025-02740-x · Cited by 1
“Additionally, it indicates increased severity of the illness [11–12],an increased likelihood of suicide [13–14],a poorer response to treatment [15],and a more extensive psychosocial damage [16–17].”
Agomelatine in the management of depression
II Klinika Psychiatryczna, I. P. I. N., Święcicki, Ł., Stefanowski, B., & II Klinika Psychiatryczna, I. P. I. N. (2018) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2018.0011 · Cited by 1
Anhedonia in Major Depressive Disorder (MDD) is Reduced by Transcranial Magnetic Stimulation (TMS)
PRIDMORE, S. A., Morey, R., PRIDMORE, S. A., & May, T. (2020) · Neurology and Neurobiology · doi:10.31487/j.nnb.2020.01.03 · Cited by 1
“A study of MDD patients treated with agomelatine found a reduction in anhedonia was a strong predictor of improved social functioning [5].”
BackgroundAgomelatyna w ocenie farmakologa i neurologa – bezpieczeństwo i zastosowanie kliniczne
Białecka, M. A. (2021) · Neuropsychiatria Przegląd Kliniczny · doi:10.24292/01.np.1312300621.1 · Cited by 1
Anhedonia in Depression: Neurobiological and Genetic Aspects
Kibitov, A. O., & Mazo, G. E. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01204-8 · Cited by 1
“Anhedonia has been found to be one of the most powerful predictors of decreased levels of psychosocial functioning and requires qualitative assessment during provision of medical care to patients with depression [12].”
BackgroundImpact, Diagnosis, Phenomenology, and Biology
Coryell, W. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_156
Bungener, C., Soumet-Leman, C., & Besche‐Richard, C. (2018) · Dunod eBooks · doi:10.3917/dunod.besce.2018.01.0023
The Effect of Electroconvulsive Therapy on Positive Affect and Hedonism in Patients With Depression
Crauwels, B., Vansteelandt, K., Obbels, J., Lambrichts, S., Pilato, E., Demyttenaere, K., & Sienaert, P. A. (2021) · Journal of Ect · doi:10.1097/yct.0000000000000818 · Cited by 1
“Finally, anhedonia has previously been associated with poor self-rated QoL in depression.(32,34,35) A discussion of the literature on QoL in ECT goes beyond the scope of the present investigation,(21,22,36,37) but the broaden-and-build theory implies that PA and hedonism may contribute to QoL by promoting flexible, cr…”
Background(2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.002.0006
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0005
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.005.0001
Continuing the Journey After Treatment
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0008
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0004
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.005.0002
(2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.002.0004
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0006
Introductory Information for Therapists
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0001
Behavioral Science and Neuroscience Identify Targets for Treatment of Anhedonia
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0002
General Treatment Format and Guiding Therapy Principles
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0003
(2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.002.0007
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.003.0007
Choi, W., Hwang, W. J., Kim, H., Kim, M., & Kwon, J. S. (2022) · 신경정신의학 · doi:10.4306/jknpa.2022.61.4.297
Abouzaid, A. M. G., & Abdelhamid, H. G. (2023) · Sohag University International Journal of Educational Research (SUIJER) /Sohag University International Journal of Educational Research (SUIJER) · doi:10.21608/suijer.2023.305894 · Cited by 1
“This is confirmed by several researchers, as Vinckier et al. (2017) found that using multivariate regression improvement in anhedonia was the strongest predictor of improvement in psychosocial functioning.”
Method(2023) · Al-Maǧallaẗ Al-Dawliyyaẗ Lil Buḥūṯ wa Al-Dirāsāt fi Al-Tarbiyyaẗ Al-H̲āṣaẗ · doi:10.21608/adba.2023.324391
(2023) · Al-Maǧallaẗ Al-Dawliyyaẗ Lil Buḥūṯ wa Al-Dirāsāt fi Al-Tarbiyyaẗ Al-H̲āṣaẗ · doi:10.21608/adba.2023.324400
Loyen, E., Bogaert, L., Hallford, D. J., D’Argembeau, A., & Raes, F. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1216988
Mobile Cognitive Interventions in Mental Disorders
Blomberg, M. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10652
Harlé, K. M., Dun, D., Spadoni, A. D., Howlett, J. R., & Simmons, A. N. (2024) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2024.100088
“While not limited to the social domain, anhedonia often manifests as a marked avoidance of social interactions and altered sense of belong-ingness promoting social isolation, i.e., “ social anhedonia ” , which has in turn been associated with poorer functional outcomes [1,2,14].”
Craske, M. G., Dour, H. J., Treanor, M., & Meuret, A. E. (2022) · Oxford University Press eBooks · doi:10.1093/med-psych/9780197548523.005.0003
Anhedonia: a unifying symptom and a transdiagnostic therapeutic target
Rosso, G., Pesci, N. R., PERACCHIA, S., Garrone, C., Salvo, G. D., & Maina, G. (2025) · Minerva Psychiatry · doi:10.23736/s2724-6612.24.02572-7
Santopetro, N. J., Thompson, B., Albanese, B. J., Brush, C. J., & Schmidt, N. B. (2025) · Psychophysiology · doi:10.1111/psyp.70067
“…suggesting that P300-related impairments in depression reflect symptoms of an-hedonia (Urretavizcaya et al. 2003; Santopetro, Brush, Burani, et al. 2021; Santopetro et al. 2022), which is also associated with chronic and treatment-resistant presentations of depression (Vinckier et al. 2017).”
Approche dimensionnelle des symptômes négatifs dans les troubles psychiatriques
Mallet, J., Pignon, B., Kaiser, S., & Cevoli, F. (2025) · médecine/sciences · doi:10.1051/medsci/2025068
Childhood P300 predicts development of depressive disorders into adolescence
Santopetro, N. J., Nelson, B. D., Hajcak, G., & Klein, D. N. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-025-01327-8
“…been associated with anhedonia symptoms in adults experiencing clinical levels of depression (Santopetro et al., 2021), which is a pernicious core symptom of the disorder linked to worse clinical outcomes, such as a more chronic and recurrent trajectory of depression (Vinckier et al., 2017).”
Cognition–Emotion Interactions
Armony, J., & Vuilleumier, P. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009342919.024
Blomberg, M., Zech, H., Kluge, M., Böhmert, N., Platte, H., & Brockmeyer, T. (2025) · JMIR mhealth and uhealth · doi:10.2196/69033
“Anhedonia predicts psychosocial functioning, depression severity, and treatment response [31, 32] and has been proposed as a potential target of change in approach-avoidance bias modification [23].”
Lin, S., Liu, R., Zhang, Z., Liu, F., Qin, S., Wei, Y., & Wang, F. (2023) · Figshare · doi:10.6084/m9.figshare.24647146
Development and Validation of the Multidimensional Adolescent Anhedonia Scale
Grocott, B. B., Zareian, B., Hewitt, J. M. A., Ge, S. Y. J., Hewitt, P. L., Hong, S., Smith, M. M., Chi, X., & LeMoult, J. (2026) · Assessment · doi:10.1177/10731911261423154
“For example, anticipatory anhedonia has been more strongly linked to depressive symptoms (Sherdell et al., 2012), whereas consummatory anhedonia is more closely related to impaired psychosocial functioning (Vinckier et al., 2017).”
Pozuelo, J. R., Kessler, R. C., Patel, V., Lahiri, A., Parashar, Y., Herzallah, M. M., Khanduri, M., O’Neill, K., Martinez, A., Bhan, A., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121674
Ambalavanar, N., Tang, B., Galinato, D. J. A., Spoelma, M. J., Newby, J. M., & Whitton, A. E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106667
Caractérisation neuro-computationnelle de l'humeur : causes et conséquences
Carrillo, P. (2024) · theses.fr (ABES) · doi:10.70675/181aec0cz429dz4bccz83f0za479cbef52f7
Portela, R., Brister, T. S., Mattingly, G. W., Drissen, T., & Bowrey, H. E. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00662-5 · Cited by 1
Zhu, C., Hu, R., Du, W., Ye, Y., Mu, Q., Chen, Y., Xu, Y., Zhang, K., & Lu, S. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08169-9
“Given that anhedonia is not only a core symptomatic dimen-sion of MDD [8] but is also associated with poorer functional outcomes and quality of life [10, 13], systematic identification and longitudinal monitoring in routine assessment are clinically warranted [49, 50].”
InfluentialWu, J., Deng, Z., Cheng, X., Qiu, N., Hu, L., Chen, Z., Yi, C., Pu, L., Yao, D., & Yan, H. (2026) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2026.05.004
Levada, O. A., Troian, O., Myshakivska, O., & Пінчук, І. (2026) · Proceedings of the Shevchenko Scientific Society Medical Sciences · doi:10.25040/ntsh2026.01.23
Pugh, D., Saunders, R., Jones, A., Dunn, B., Suh, J. W., Stott, J. C. H., Wheatley, J., Pilling, S., & Buckman, J. E. J. (2026) · Psychological Medicine · doi:10.1017/s0033291726104875
Anticipate, experience, strengthen: a network analysis of daily life positive affect dynamics
Pacheco-Romero, A. M., Hoorelbeke, K., Vázquez, C., & Sánchez-López, Á. (2026) · Motivation and Emotion · doi:10.1007/s11031-026-10259-w
Yang, X., Huang, Y., Liu, W., Wu, T., Liu, Z., Gao, S., Zheng, Q., Dou, Z., Zheng, J., Meng, S., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03794-y
Boyle, C. C., Blandl, F., Eisenberger, N. I., Olmstead, R., Cho, J. H., Piber, D., & Irwin, M. R. (2026) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2026.107987
Losiewicz, O. M., Zbozinek, T. D., Cohen, Z. D., Akre, S., Bui, A. A. T., & Craske, M. G. (2026) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2026.101163
Matteo, I. D., Lavigne, K. M., & Raucher‐Chéné, D. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117532
Metadata
- Authors
- Vinckier, F., Gourion, D., & Mouchabac, S.
- Affiliations
- Sorbonne Paris Cité (FR)
- Sorbonne Université (FR)
- Corresponding author
- Vinckier, F.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2017-07
- Volume
- 44
- Pages
- 1-8
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2592834759
- Cited by
- 201
- References
- 43
- Citations by year
- 2026: 22 · 2025: 44 · 2024: 29 · 2023: 22 · 2022: 35 · 2021: 16 · 2020: 13 · 2019: 14 · 2018: 4 · 2017: 2
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- anhedonia, major depressive disorder, psychosocial functioning, social functioning, agomelatine, antidepressant response, prognostic factors, general practitioners, mediation analysis
- MeSH terms
- Adaptation, Psychological, Adult, Antidepressive Agents, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Outpatients, Severity of Illness Index, Social Adjustment, Cohort Studies, Treatment Outcome, General Practitioners, Anhedonia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review